INFINITE GROUP INC

2022 Q3 Form 10-Q Financial Statement

#000165495422011399 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.580K $1.590K $104.9K
YoY Change -88.27% -59.95% 146.88%
Cash & Equivalents $6.584K $1.594K $104.8K
Short-Term Investments
Other Short-Term Assets $177.5K $198.2K $240.0K
YoY Change 19.43% 9.31% 123.65%
Inventory
Prepaid Expenses
Receivables $585.8K $650.4K $666.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $769.9K $850.2K $1.011M
YoY Change -17.84% -13.42% 7.03%
LONG-TERM ASSETS
Property, Plant & Equipment $25.44K $30.98K $56.52K
YoY Change -44.17% -34.39% -61.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.14K $10.14K $6.940K
YoY Change 46.11% 46.11% 0.0%
Total Long-Term Assets $1.123M $1.147M $479.7K
YoY Change 110.99% 113.51% -10.04%
TOTAL ASSETS
Total Short-Term Assets $769.9K $850.2K $1.011M
Total Long-Term Assets $1.123M $1.147M $479.7K
Total Assets $1.893M $1.997M $1.491M
YoY Change 28.84% 31.46% 0.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.294M $1.087M $860.7K
YoY Change 151.12% 203.46% 189.23%
Accrued Expenses $1.890M $1.521M $1.629M
YoY Change 27.64% 8.18% 16.2%
Deferred Revenue
YoY Change
Short-Term Debt $1.477M $1.173M $823.6K
YoY Change 365.08% 489.21% 406.8%
Long-Term Debt Due $1.060M $765.0K $765.0K
YoY Change 38.86% -5.29% -30.84%
Total Short-Term Liabilities $6.235M $5.315M $4.862M
YoY Change 76.55% 58.03% 50.01%
LONG-TERM LIABILITIES
Long-Term Debt $1.433M $1.458M $1.446M
YoY Change -6.98% -7.64% 5.06%
Other Long-Term Liabilities $592.5K $612.1K $0.00
YoY Change 758.35% 786.77% -100.0%
Total Long-Term Liabilities $2.026M $2.070M $1.446M
YoY Change 25.84% 25.66% -1.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.235M $5.315M $4.862M
Total Long-Term Liabilities $2.026M $2.070M $1.446M
Total Liabilities $8.261M $7.385M $6.308M
YoY Change 60.67% 47.39% 33.99%
SHAREHOLDERS EQUITY
Retained Earnings -$38.26M -$37.17M -$36.34M
YoY Change 10.13% 7.84%
Common Stock $453.00 $33.56K $32.70K
YoY Change -98.57% 13.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.367M -$5.388M -$4.817M
YoY Change
Total Liabilities & Shareholders Equity $1.893M $1.997M $1.491M
YoY Change 28.84% 31.46% 0.87%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000884650
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9710 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32700883 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33561124 shares
imci Weighted Average Exercise Price Outstanding Beginning
WeightedAverageExercisePriceOutstandingBeginning
0.08
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.13
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.04
imci Weighted Average Exercise Price Outstanding Ending
WeightedAverageExercisePriceOutstandingEnding
0.08
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.07
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.07
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21816
dei Entity Registrant Name
EntityRegistrantName
INFINITE GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1490422
dei Entity Address Address Line1
EntityAddressAddressLine1
175 Sully’s Trail
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 202
dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsford
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
14534
dei City Area Code
CityAreaCode
585
dei Local Phone Number
LocalPhoneNumber
385-0610
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33961124 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1594 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99432 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9710 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
650403 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
727297 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
198220 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
218821 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
850217 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1045550 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41490 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30982 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41138 usd
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
421224 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
417650 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
425839 usd
CY2022Q2 us-gaap Deposits Assets
DepositsAssets
10144 usd
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
6937 usd
CY2022Q2 us-gaap Assets
Assets
1997119 usd
CY2021Q4 us-gaap Assets
Assets
1552765 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1086528 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
536863 usd
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
341691 usd
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
670117 usd
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
594241 usd
CY2022Q2 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
280958 usd
CY2021Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
275422 usd
CY2022Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
475400 usd
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
497734 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
154729 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
167310 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
73030 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
42347 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
765000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
765000 usd
CY2022Q2 imci Ong Term Debt And Capital Lease Obligations Including Current Maturities
ongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
295000 usd
CY2021Q4 imci Ong Term Debt And Capital Lease Obligations Including Current Maturities
ongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
190000 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
943521 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
383824 usd
CY2022Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
229000 usd
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
229000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5314974 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4107580 usd
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
458576 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
458309 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
998975 usd
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
1084765 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
612136 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q2 us-gaap Liabilities
Liabilities
7384661 usd
CY2021Q4 us-gaap Liabilities
Liabilities
5650654 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33561124 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32700883 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
33560 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
32700 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31747693 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31336772 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37168795 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-35467361 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5387542 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4097889 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1997119 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1552765 usd
CY2022Q2 us-gaap Revenues
Revenues
1696492 usd
CY2021Q2 us-gaap Revenues
Revenues
1797504 usd
us-gaap Revenues
Revenues
3363562 usd
us-gaap Revenues
Revenues
3621846 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
1059639 usd
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
1109223 usd
us-gaap Cost Of Revenue
CostOfRevenue
2180879 usd
us-gaap Cost Of Revenue
CostOfRevenue
2182138 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
636853 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
688281 usd
us-gaap Gross Profit
GrossProfit
1182683 usd
us-gaap Gross Profit
GrossProfit
1439708 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
613317 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
541711 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1217300 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1006103 usd
CY2022Q2 us-gaap Selling Expense
SellingExpense
612957 usd
CY2021Q2 us-gaap Selling Expense
SellingExpense
507042 usd
us-gaap Selling Expense
SellingExpense
1260582 usd
us-gaap Selling Expense
SellingExpense
894767 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1226274 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
1048753 usd
us-gaap Operating Expenses
OperatingExpenses
2477882 usd
us-gaap Operating Expenses
OperatingExpenses
1900870 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-589421 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-360472 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1295199 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-461162 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
10 usd
CY2021Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
1 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
18 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
3 usd
CY2022Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
22728 usd
CY2021Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
16541 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
46142 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
31054 usd
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
221061 usd
CY2021Q2 us-gaap Interest Expense Other
InterestExpenseOther
39491 usd
us-gaap Interest Expense Other
InterestExpenseOther
360111 usd
us-gaap Interest Expense Other
InterestExpenseOther
76517 usd
CY2022Q2 imci Interest Expenses
InterestExpenses
-243789 usd
CY2021Q2 imci Interest Expenses
InterestExpenses
-56032 usd
imci Interest Expenses
InterestExpenses
-406253 usd
imci Interest Expenses
InterestExpenses
-107571 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-243779 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-56031 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-406235 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-107568 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-833200 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-416503 usd
us-gaap Net Income Loss
NetIncomeLoss
-1701434 usd
us-gaap Net Income Loss
NetIncomeLoss
-568730 usd
CY2022Q2 imci Income Loss From Continuing Operations Per Common Basic And Diluted Share
IncomeLossFromContinuingOperationsPerCommonBasicAndDilutedShare
-0.03
CY2021Q2 imci Income Loss From Continuing Operations Per Common Basic And Diluted Share
IncomeLossFromContinuingOperationsPerCommonBasicAndDilutedShare
-0.01
imci Income Loss From Continuing Operations Per Common Basic And Diluted Share
IncomeLossFromContinuingOperationsPerCommonBasicAndDilutedShare
-0.05
imci Income Loss From Continuing Operations Per Common Basic And Diluted Share
IncomeLossFromContinuingOperationsPerCommonBasicAndDilutedShare
-0.02
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33296434 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29238323 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33000304 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29150590 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33296434 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29238323 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33000304 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29150590 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4097889 usd
CY2022Q1 imci Stock Based Compensation Amount
StockBasedCompensationAmount
923 usd
CY2022Q1 imci Warrants Issued Amount
WarrantsIssuedAmount
148334 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-868234 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4816866 usd
CY2022Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2022Q2 imci Stock Based Compensation Amount
StockBasedCompensationAmount
51708 usd
CY2022Q2 imci Warrants Issued Amount
WarrantsIssuedAmount
210816 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-833200 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5387542 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3105770 usd
CY2021Q1 imci Stock Based Compensation Amount
StockBasedCompensationAmount
28248 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-152227 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-3229749 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
58125 usd
CY2021Q2 imci Exercise Of Stock Options Amount
ExerciseOfStockOptionsAmount
14930 usd
CY2021Q2 imci Stock Based Compensation Amount
StockBasedCompensationAmount
81920 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-416503 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-3491277 usd
us-gaap Profit Loss
ProfitLoss
-1701434 usd
us-gaap Profit Loss
ProfitLoss
-568730 usd
us-gaap Share Based Compensation
ShareBasedCompensation
52631 usd
us-gaap Share Based Compensation
ShareBasedCompensation
110168 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
117686 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
87551 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
255042 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
76894 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
157170 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
17394 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-26730 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
549665 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14978 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-22334 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
109424 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12014 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
98469 usd
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
5536 usd
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
5320 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-636906 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12380 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
969 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8722 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
110378 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
121175 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-111347 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-129897 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
918900 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
53445 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
299000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
215040 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14930 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
200000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
650415 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113930 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-97838 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28347 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99432 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32313 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1594 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3966 usd
us-gaap Interest Paid Net
InterestPaidNet
54826 usd
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
704000 usd
us-gaap Interest Paid Net
InterestPaidNet
39369 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
691009 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-1701434 usd
us-gaap Net Income Loss
NetIncomeLoss
-568730 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5387542 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4097889 usd
CY2022Q2 imci Working Capital Deficit
WorkingCapitalDeficit
4400000 usd
us-gaap Stock Issued1
StockIssued1
15000000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
15000000 usd
us-gaap Reclassifications
Reclassifications
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;"><strong>Reclassifications </strong>– It is the Company’s policy to reclassify prior year amounts to conform with the current year presentation.</p>
CY2022Q2 us-gaap Revenues
Revenues
1696492 usd
CY2021Q2 us-gaap Revenues
Revenues
1797504 usd
us-gaap Revenues
Revenues
3363562 usd
us-gaap Revenues
Revenues
3621846 usd
imci Retained Amount Rate
RetainedAmountRate
0.10 pure
imci Prime Plus Rate
PrimePlusRate
0.036 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0835 pure
CY2022Q2 imci Maximum Limit Of Financing Line
MaximumLimitOfFinancingLine
2000000 usd
imci Sublimit On Accounts Receivable
SublimitOnAccountsReceivable
1500000 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
789350 usd
CY2021 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
678973 usd
CY2022Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
368126 usd
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
261323 usd
CY2022Q2 imci Amortization Expense
AmortizationExpense
53402 usd
imci Amortization Expense
AmortizationExpense
106803 usd
CY2021Q2 imci Amortization Expense
AmortizationExpense
39844 usd
imci Amortization Expense
AmortizationExpense
74794 usd
CY2022Q2 us-gaap Development Costs
DevelopmentCosts
7800 usd
us-gaap Development Costs
DevelopmentCosts
16100 usd
CY2021Q2 us-gaap Development Costs
DevelopmentCosts
46900 usd
us-gaap Development Costs
DevelopmentCosts
87700 usd
CY2022Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
136100 usd
CY2021Q2 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
132800 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
278300 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
210300 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
360000 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
750000 shares
CY2022Q2 imci Option Price
OptionPrice
0.245
us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
250000 shares
CY2022Q2 imci Recognized Compensation
RecognizedCompensation
45275 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
90550 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-833200 usd
CY2022Q2 imci Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.03
CY2021Q2 imci Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.01
imci Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.05
imci Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.02
CY2022Q2 imci Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
33296434 shares
CY2021Q2 imci Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
29238323 shares
imci Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
33000304 shares
imci Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
29150590 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23148234 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23951234 shares
CY2022Q2 imci Aggregate Shares Of Common Stock Authorized Under Stock Option Plans And Agreements
AggregateSharesOfCommonStockAuthorizedUnderStockOptionPlansAndAgreements
16304500 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
95000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
575000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M
CY2022Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
51708 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52631 usd
CY2021Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
81920 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
110168 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
73030 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
42347 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
612136 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
imci Number Of Options Outstanding Beginning
NumberOfOptionsOutstandingBeginning
10755000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
95000 shares
imci Number Of Options Expired
NumberOfOptionsExpired
-347500 shares
imci Number Of Options Outstanding Ending
NumberOfOptionsOutstandingEnding
10502500 shares
imci Sharebased Compensation Arrangement By Sharebased Payment Award Option Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionOutstandingWeightedAverageRemainingContractualTerm2
P2Y10M24D
imci Aggregate Intrinsic Value Outstanding
AggregateIntrinsicValueOutstanding
870900 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9992500 shares
imci Sharebased Compensation Arrangement By Sharebased Payment Award Option Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
870900 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9992500 shares
imci Sharebased Compensation Arrangement By Sharebased Payment Award Option Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionExercisableWeightedAverageRemainingContractualTerm1
P2Y10M24D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
870900 usd
imci Leases Expires
LeasesExpires
June 30, 2022
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
80000 usd
imci Leases Rate
LeasesRate
0.015 pure
imci Description Of Lease Agreement
DescriptionOfLeaseAgreement
The term of the new lease agreement is 84 months. The first year’s rent will be $118,487 and will increase by 2% annually thereafter
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
684552 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41490 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
685166 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
42347 usd
CY2022Q2 imci Discount Rate Operating Leas
DiscountRateOperatingLeas
0.070 pure
CY2021Q4 imci Discount Rate Operating Leas
DiscountRateOperatingLeas
0.060 pure
CY2022Q2 imci Related Party Interest Payable Current
RelatedPartyInterestPayableCurrent
134000 usd
CY2021Q4 imci Related Party Interest Payable Current
RelatedPartyInterestPayableCurrent
107000 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
136675 usd

Files In Submission

Name View Source Status
0001654954-22-011399-index-headers.html Edgar Link pending
0001654954-22-011399-index.html Edgar Link pending
0001654954-22-011399.txt Edgar Link pending
0001654954-22-011399-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
imci-20220630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
imci-20220630_cal.xml Edgar Link unprocessable
imci-20220630_def.xml Edgar Link unprocessable
imci_10q.htm Edgar Link pending
imci_ex311.htm Edgar Link pending
imci_ex312.htm Edgar Link pending
imci_ex321.htm Edgar Link pending
imci_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
imci-20220630_pre.xml Edgar Link unprocessable
imci_10q_htm.xml Edgar Link completed
imci-20220630_lab.xml Edgar Link unprocessable